Gemcal-D3

Quick links to important sections

Gemcal-D3

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gemcal-D3

Property Description
Active Ingredients Elemental Calcium, Cholecalciferol (Vitamin D3)
Form Oral Capsule or Tablet
Pharmacological Class Vitamin and Mineral Combination, Calcium Supplements
Common Use Supplementation for Bone Health Maintenance
Origin Essential Mineral and Fat-Soluble Sterol Derivative

Gemcal-D3 is a vitamin and mineral combination supplement used to provide the essential micronutrients, calcium and vitamin D3. As an oral medicinal preparation, it is classified within the pharmacological group of Vitamin and Mineral Combinations. This product is a clinically recognized fixed-composition preparation designed to address dietary gaps in these essential components, often marketed towards adults and the elderly. Vitamin D supplementation is an effective measure in increasing the intestinal absorption of calcium in patients with low levels of the vitamin.

Elemental Calcium, Vitamin D3, and Compositional Origin

Gemcal-D3 is composed of the active ingredients Elemental Calcium and Cholecalciferol, which is the chemical name for Vitamin D3. The Elemental Calcium component is derived from a concentrated calcium salt, typically Calcium Carbonate, which serves as the fundamental mineral required by the body. Cholecalciferol is a crucial fat-soluble sterol derivative, and its inclusion in the combination is essential, as its presence actively enhances the efficiency of mineral uptake. Calcium is the most abundant mineral in the human body, with 99% found in the bones and teeth.

General Purpose: Support for Bone Homeostasis

The general purpose of Gemcal-D3 is to provide fundamental support for skeletal integrity and maintain consistent calcium and phosphate homeostasis. The dual-component nature is clinically recognized for ensuring the availability of both the structural material and the necessary biological cofactor (Cholecalciferol) to enable its effective utilization. This combined supplementation strategy supports the availability of calcium required for both bone formation and critical physiological processes, such as nerve transmission and muscle function.

What side effects are possible with Gemcal-D3?

Possible Side Effects and Safety Information

The safety profile of elemental calcium and cholecalciferol (Vitamin D3) combination products is primarily defined by the risk of hypercalcaemia (high calcium levels in the blood) and hypercalciuria (high calcium excretion in the urine), as documented in official regulatory sources. The adverse reactions are classified by frequency based on clinical and post-marketing data.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects
Uncommon Hypercalcaemia, Hypercalciuria
Rare Constipation, Flatulence, Nausea, Abdominal pain, Diarrhoea, Dyspepsia, Pruritus, Rash, Urticaria
Very Rare Milk-alkali syndrome

Adverse reactions are grouped by System-Organ Class (SOC) in regulatory documents, with the most frequently affected systems being Metabolism and Nutrition Disorders and Gastrointestinal Disorders.

Serious Adverse Reactions and Safety Constraints

The most serious reaction documented is the milk-alkali syndrome, which involves the severe combination of hypercalcaemia, metabolic alkalosis, and renal impairment, typically associated with chronic overdosage. Furthermore, sustained, excessive mineral levels may potentially lead to irreversible renal damage or cardiac arrhythmias in vulnerable patients.

The product is contraindicated and must not be used in individuals with pre-existing conditions such as hypercalcaemia, hypercalciuria, nephrolithiasis (kidney stones), severe renal insufficiency, or Hypervitaminosis D. Use in immobilized patients with osteoporosis or those with sarcoidosis requires particular caution, as specified in regulatory labeling. Overdoses of calcium and Vitamin D must also be avoided during pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage involving the combination of Calcium and Vitamin D3 (Cholecalciferol) is considered a potentially serious condition. The primary and most dangerous clinical manifestation of overdose is hypercalcaemia (excessive calcium in the blood), which can lead to complications related to high calcium levels.

Documented Overdose Symptoms

The symptoms of hypercalcaemia often start with non-specific issues and may worsen with severity. Early manifestations can include:

  • Digestive issues: Nausea, vomiting, loss of appetite, constipation, and abdominal pain.
  • Systemic effects: Weakness, fatigue, excessive thirst (polydipsia), and frequent urination (polyuria).
  • Neurological effects: Headache, mental disturbances, confusion, or somnolence (drowsiness).

In severe or chronic cases, excessive intake can lead to calcification of soft tissues and blood vessels, kidney damage (nephrocalcinosis, kidney stones), cardiac arrhythmias, and may progress to coma and death.

Required Emergency Action

Immediate medical attention is required if you or anyone else accidentally takes too much of this product. Consult a doctor immediately or visit the nearby hospital if symptoms of overdose, such as severe or persistent vomiting, increased thirst, or confusion, are observed.

General treatment for hypercalcaemia resulting from overdose involves the immediate and complete discontinuation of the product, followed by supportive measures as directed by a healthcare professional.

Therapeutic Uses of Gemcal-D3

What Gemcal-D3 Treats: Main Uses and Benefits

The application of Gemcal-D3 is relevant for easing certain distressing symptoms associated with calcium and Vitamin D deficiencies. It is applicable within clinical settings that involve acute or disruptive symptom patterns due to mineral imbalances. The combination of Vitamin D3 and calcium is commonly used to help with managing symptoms related to bone conditions such as rickets, osteomalacia, and osteoporosis.

This combination is applied across domains where additional symptomatic support is appropriate. It helps manage conditions presenting with systemic imbalance and functional strain.

“Gemcal-D3 supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load.”

Key Symptomatic Support

The medication helps address symptom clusters that may become intense or disruptive in conditions where functional stability becomes affected, or where symptoms are related to increased neurological or muscular activity. It is relevant for easing symptoms like muscle cramps, bone weakness, and tingling sensations. It is commonly used to help with symptoms related to increased physiological stress during **pregnancy, breastfeeding, and geriatric care.


Quick Fact: Relief for Acute Symptoms

The combination may assist with managing symptoms related to heightened physiological activity, such as painful muscle spasms, often used in settings marked by temporary physiological imbalance.

Eligibility and Restrictions for Use

Who Can and Cannot Use Gemcal-D3? — Official Regulatory Information

The eligibility profile for Gemcal-D3 (Calcium and Vitamin D3) is strictly defined by regulatory documents, focusing on existing metabolic conditions and organ function.


Populations for Whom Use is Contraindicated

Use is absolutely prohibited for patients diagnosed with: Hypercalcaemia (high blood calcium levels), Hypercalciuria (high urinary calcium excretion), or Hypervitaminosis D (Vitamin D overdosage). It is also contraindicated in individuals with severe renal impairment and those with a history of nephrolithiasis (kidney stones).


Age and Special Population Restrictions

Population Group Regulatory Status
Adults and Elderly Use is generally established for deficiency treatment.
Paediatric Population Standard adult-dose formulations are not recommended; specialized dosage selection is required.
Pregnancy and Lactation Use is conditional and restricted to low therapeutic doses; high doses are not recommended due to risk of hypercalcaemia.

Condition-Specific Eligibility Restrictions

Patients with non-severe renal impairment or sarcoidosis require conditional use and must undergo continuous monitoring of serum calcium levels. Use is also restricted in immobilized patients with osteoporosis due to an increased risk of hypercalcaemia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents indicate that the interaction profile of products containing Calcium Carbonate and Cholecalciferol (Vitamin D3) is primarily structured around the modification of drug absorption and the risk of additive systemic effects.

Interactions Affecting Absorption (Timing-Based Constraints)

The calcium component can reduce the absorption and effectiveness of several co-administered medicinal products, often through chelation or by altering gastric pH.

Interacting Product Category Example Medicines Interaction-Related Constraint
Antibiotics Tetracyclines, Fluoroquinolones (e.g., Ciprofloxacin) Administration must be separated by a defined time interval to minimize reduced absorption.
Hormones & Bone Agents Levothyroxine, Bisphosphonates (e.g., Alendronate) Administration must be separated by a defined time interval.

Interactions Affecting Metabolism and Systemic Effects

Other interactions may reduce the absorption of Vitamin D3 or increase the risk of elevated calcium levels in the body.

  • Cardiac Glycosides (e.g., Digoxin): Concomitant use increases the risk of heart rhythm disturbances, particularly if elevated calcium levels occur.
  • Diuretics (Thiazide): Co-administration can increase the risk of hypercalcemia, especially in the elderly.
  • Fat-Soluble Vitamin Inhibitors: Medicines like Orlistat, Mineral oil, and Bile acid sequestrants (e.g., Cholestyramine) decrease the intestinal absorption of the Vitamin D3 component.

Patients are advised not to take other calcium or Vitamin D supplements concurrently due to the risk of high serum levels.

Mechanism of Action

Gemcal-D3 is a fixed-dose combination containing calcium carbonate and cholecalciferol (Vitamin D3). The pharmacodynamic action of this combination is governed by the independent mechanisms of its two components.

Calcium Carbonate Mechanism

Upon ingestion, calcium carbonate dissolves into elemental calcium ions (Ca^2+). These ions are absorbed primarily in the duodenum and jejunum via both paracellular diffusion and active transcellular transport involving the epithelial calcium channel TRPV6 and the calcium-binding protein calbindin-D9k. The absorbed Ca^2+ enters the systemic circulation, where it participates in numerous physiological processes, including serving as a structural component of the skeletal matrix and modulating excitation-contraction coupling in muscle tissue.


Cholecalciferol (Vitamin D3) Mechanism

Cholecalciferol, an inactive precursor, undergoes two sequential hydroxylation steps: first in the liver by CYP2R1 to form 25-hydroxyvitamin D3 (calcifediol), and then in the kidney by CYP27B1 (1-alpha-hydroxylase) to produce the active hormone, calcitriol (1,25-(OH)2D3). Calcitriol functions as an agonist for the nuclear Vitamin D Receptor (VDR), a ligand-activated transcription factor. Upon binding, the calcitriol-VDR complex heterodimerizes with the Retinoid X Receptor (RXR) and translocates to the nucleus. This complex binds to specific Vitamin D Response Elements (VDREs) on the genome, modulating the transcription of target genes. Key downstream effects include upregulation of TRPV6 and calbindin-D9k in the intestinal mucosa, thereby increasing the rate of active transcellular Ca^2+ absorption, and promoting the reabsorption of Ca^2+ from the renal tubules.

Dosage and Administration Information

How to Use Gemcal-D3

This section describes the high-level, label-based administration principles for products containing the combination of Elemental Calcium and Cholecalciferol (Vitamin D3).


Administration and Dosage Regimen

The approved route for this combination is oral administration, typically available in forms such as tablets, capsules, or chewable tablets. The standard adult dosing regimen is designed to address combined deficiencies or serve as an adjunct to osteoporosis therapy.

Standard Labeled Dosing: Doses commonly deliver a total daily intake of 1000 mg to 1200 mg of Elemental Calcium and 400 IU to 1000 IU of Cholecalciferol. The dosing frequency is generally once daily for high-strength formulations or twice daily for lower-strength combinations to achieve the intended total daily dose. The upper limit for combined intake from all sources should not exceed 2500 mg of calcium and 4000 IU of vitamin D.


Administration Conditions and Constraints

Condition Official Administration Instruction
Timing Relative to Meals May be taken with or without food, although some product labels advise taking the dose during a meal.
Chewable Forms Chewable tablets must be chewed or sucked completely before swallowing.
Concomitant Medications A required time separation (e.g., at least two to four hours before or after) is necessary when administering this product with certain other oral medications, such as tetracyclines or levothyroxine, to prevent interference with drug absorption.
Population Use Dosing for the elderly is typically the same as for adults. The product is generally not recommended for patients with severe renal impairment.
Long-Term Use For extended periods of administration, it is advised to conduct a periodic review of the need for continued therapy.

These instructions collectively define the standardized oral administration protocol, ensuring the prescribed daily dose is taken correctly while accounting for potential usage constraints related to other medicines and the tablet form.

Recent Clinical Evidence

Gemcal-D3: Recent Clinical Evidence

Gemcal-D3 is a nutritional supplement containing Calcium Carbonate and Cholecalciferol (Vitamin D3), utilized to manage deficiencies and support bone health. Clinical research often focuses on the efficacy of this combination for conditions like osteoporosis (bone loss), osteomalacia (soft bones), and rickets (in children), particularly in individuals whose diet and sun exposure are insufficient.


Efficacy in Bone Health and Fracture Prevention

Recent meta-analyses examining the combined use of calcium and vitamin D supplementation generally support its role, particularly in certain at-risk populations. A significant body of evidence suggests that adequate supplementation with calcium and vitamin D may help reduce the risk of total fractures and hip fractures in older, non-institutionalized adults, and especially in individuals with known vitamin D deficiency or those residing in institutionalized settings. However, the exact benefit for fracture prevention in all community-dwelling adults without a diagnosed deficiency remains a topic of ongoing research and debate.


Mechanism of Action and Clinical Markers

The benefit of this combination relies on their established biological functions. Vitamin D3 is crucial as it promotes the absorption of calcium from the intestine, which is then incorporated into the bone matrix to maintain density and strength. Clinical trials frequently demonstrate that supplementation successfully raises circulating levels of 25-hydroxyvitamin D in the blood. Furthermore, the combination therapy can help suppress parathyroid hormone (PTH) levels, which, when elevated due to calcium deficiency, can otherwise lead to increased bone breakdown (resorption).

Key Studies & References

  1. Effect of Vitamin D Supplementation on Risk of Fractures and Falls According to Dosage and Interval: A Meta-Analysis
  2. Vitamin D deficiency - Clinical Practice Guidelines - The Royal Children's Hospital (RCH)
  3. SEL Clinical Guideline for the Management of Vitamin D insufficiency and deficiency in Adults
  4. Human Drug Label: High Potency Calcium - calcium 600mg and 10 mcg vitamin d3 tablet, film coated (DailyMed/NIH)
  5. Calcium with Vitamin D3 Gemcal D3 - Manufacturer's Product Monograph (Alkem Laboratories)

Frequently Asked Questions (FAQ)

Common questions about Gemcal-D3 (FAQ)

Q: How is Gemcal-D3 different from just taking plain calcium tablets?

A: Gemcal-D3 is a combination product that includes both calcium and Vitamin D3 (Cholecalciferol). Official information indicates that the Vitamin D3 component is crucial because it significantly enhances the intestinal absorption of the calcium. This dual combination is used to ensure more effective utilization of the mineral for bone health.

Q: Does Gemcal-D3 help with muscle cramps or weakness?

A: The calcium component in Gemcal-D3 is a mineral known to be essential for supporting normal nerve transmission and muscle function. Conversely, official safety information indicates that very high levels of calcium (hypercalcaemia) caused by overdose may potentially result in adverse effects, including muscle weakness and pain.

Q: How long does it usually take to notice an effect from taking Gemcal-D3?

A: Regulatory documents do not specify a timeframe for when a patient will 'notice' an effect. Correction of Vitamin D deficiency often involves a specific regimen. For long-term use, the focus is on maintaining blood levels, which is verified through required periodic monitoring rather than immediate subjective effects.

Q: Can Gemcal-D3 be taken with or without food?

A: According to official product information, Gemcal-D3 can generally be taken either with or without food. However, some specific product labels may suggest taking the supplement during a meal. This information is found in the administration instructions.

Q: What happens if I miss a dose of Gemcal-D3?

A: Regulatory documents typically indicate that if a dose is missed, it can be taken once remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule should be continued. It is generally advised to avoid taking a double dose to compensate for a missed dose.

Q: Are there specific dietary restrictions while taking Gemcal-D3?

A: Yes, regulatory warnings regarding absorption apply to certain foods. Official warnings recommend separating the consumption of foods containing oxalic acid (such as spinach or rhubarb) or phytic acid (found in whole grains) from the supplement dose by at least two hours to prevent interference with calcium absorption.

Q: Can Gemcal-D3 be crushed or chewed if swallowing is difficult?

A: If the product is supplied as a chewable tablet, official instructions state it must be chewed or sucked completely before swallowing. Regulatory documents typically do not provide guidance for crushing or chewing standard capsules or film-coated tablets, which generally implies they should be swallowed whole.

Q: Is it normal to feel slightly nauseous after starting Gemcal-D3?

A: Nausea is listed in official safety documents as a documented, though rare, side effect associated with the product. It is also important to note that severe nausea and vomiting are recognized warning signs that could indicate an overdose (hypercalcaemia).

Q: How should I space out taking Gemcal-D3 if I'm taking other medicines?

A: Official guidance mandates a separation period to prevent the calcium component from interfering with the absorption of other medicines. Gemcal-D3 should be taken at least two to four hours before or after taking certain products, including specific antibiotics, iron supplements, and thyroid hormones like levothyroxine.

Q: Is Gemcal-D3 manufactured in different strengths?

A: Yes, regulatory documents for these types of combination products confirm that they are manufactured in multiple strengths. The availability of different strengths allows for the appropriate dose of Elemental Calcium and Cholecalciferol (Vitamin D3) to be selected to meet individual patient needs.

Q: Do caffeine or alcohol consumption affect how Gemcal-D3 works?

A: Official regulatory documents do not list interactions with moderate caffeine consumption. While not listed as a direct drug interaction, excessive alcohol intake may potentially affect the body's metabolism and absorption of vitamins and minerals in a general sense.

Q: Is it true that Gemcal-D3 is sometimes recommended for pregnant women?

A: Use of this product during pregnancy is conditional and limited to low therapeutic doses as determined by a professional. Official guidelines caution against high doses because of the risk of hypercalcaemia (high blood calcium), which has been linked to harmful effects on the developing fetus.

Q: Can Gemcal-D3 cause any changes in urine color or frequency?

A: While changes in urine color are not a listed side effect, the regulatory warnings highlight the risk of Hypercalciuria, or excessive excretion of calcium in the urine. This condition, particularly in cases of overdose, can potentially lead to increased urination (polyuria).

Q: Are there any specific warning signs that mean I should stop taking Gemcal-D3?

A: Regulatory warnings list signs of potential overdose (hypercalcaemia), such as excessive thirst, frequent urination, persistent nausea/vomiting, unusual fatigue, or bone/muscle pain. If these or any other severe symptoms occur, professional medical guidance is necessary.

Q: What is the maximum duration someone should take Gemcal-D3 continuously?

A: There is no single maximum duration specified in regulatory documents. For patients on long-term treatment, guidelines advise the periodic review of the continued need for the therapy. This process typically includes regular monitoring of calcium levels in the blood and urine to ensure safety and effectiveness.

Q: Can taking Gemcal-D3 affect my sleep?

A: Official product information states that this combination product has no known effects on the ability to drive or use machines. However, symptoms of hypercalcaemia (overdose), such as apathy and fatigue, are documented side effects that could indirectly disrupt normal sleep patterns.

Q: Does Gemcal-D3 require a prescription, or is it over-the-counter?

A: The regulatory status can vary by country and by the strength of the product. Similar calcium and Vitamin D combination products are often sold over-the-counter (OTC) as a nutritional supplement, but higher-strength formulations intended for specific therapeutic treatment may require a prescription.

Q: Does Gemcal-D3 need to be refrigerated?

A: No, regulatory storage guidelines state the product should be kept at controlled room temperature, typically below 30 C (86 F). It must also be protected from moisture and light, and should not be frozen.

Q: Is Gemcal-D3 considered a nutritional supplement or a medication?

A: The product is officially classified as a Vitamin and Mineral Combination. While it supports nutritional needs, depending on the jurisdiction and strength, it is regulated as a medicinal product used for the prevention and treatment of deficiencies.

Q: Is Gemcal-D3 gluten-free?

A: Official regulatory documents list all inactive ingredients, or excipients, in a drug. While gluten is not a common primary excipient, final suitability should be confirmed by reviewing the full list of excipients for the specific product formulation.

How should Gemcal-D3 be stored and disposed of?

Official Storage and Handling Requirements

Gemcal-D3, a combination of elemental calcium and cholecalciferol (Vitamin D3), must be stored according to regulatory standards to maintain its stability.

Condition Requirement (Based on Official Labeling)
Temperature Store at controlled room temperature, typically below 30 C (86 F). Do not freeze.
Protection Keep the medicine in a dry place and protect from light and moisture.
Packaging Store in the original container and ensure the cap is tightly closed.
Child Safety Keep out of the reach of children and out of sight.

Disposal Instructions

Regulatory instructions require that unused or expired Gemcal-D3 must be disposed of according to local regulations. To prevent environmental contamination, the product should not be discarded into household wastewater or flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Gemcal-D3 found in:

A-Z Index: